New Delhi, March 31, 2025.
Starting April 1, the prices of nearly 400 essential medicines, including those used for treating infections, diabetes, and heart diseases, will increase by 1.74%. The National Pharmaceutical Pricing Authority (NPPA) announced the routine price adjustment, which is done annually to align with the market.
The price revision is based on the Wholesale Pricing Index (WPI) of the previous year. The NPPA’s office memorandum stated that the WPI increased by 1.74% in 2024 compared to 2023, allowing manufacturers to adjust the maximum retail price of scheduled formulations without prior government approval.
